Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „when“
Suchtreffer
Begriffe & Kennungen
Docetaxel Kabi · 4.3 · Contraindications for other medicinal products also apply, when combined with docetaxel.
Eintrag öffnenDocetaxel Kabi · 4.3 · Contraindications for other medicinal products also apply, when combined with docetaxel.
Eintrag öffnenDoptelet · 4.5 · Increase the recommended starting dose of Doptelet when used concomitantly with a moderate or strong dual indu
Eintrag öffnenDoptelet · 4.5 · Reduce the starting dose of avatrombopag when used concomitantly with a moderate or strong dual inhibitor of C
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.8 · When pretomanid in BPaL regimen was administered along with moxifloxacin in the TB- PRACTECAL trial in BPaLM a
Eintrag öffnenDrovelis · 4.5 · 12 When co-administered with CHCs, many combinations of HIV protease inhibitors and non-nucleoside reverse tra
Eintrag öffnenDuloxetine Lilly · 4.5 · Anticoagulants and antiplatelet agents: Caution should be exercised when duloxetine is combined with oral anti
Eintrag öffnenDuloxetine Lilly · 4.5 · Medicinal products metabolised by CYP2D6: Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was ad
Eintrag öffnenDuloxetine Lilly · 4.8 · c. Description of selected adverse reactions Discontinuation of duloxetine (particularly when abrupt) commonly
Eintrag öffnenDuloxetine Zentiva · 4.5 · Anticoagulants and antiplatelet agents Caution should be exercised when duloxetine is combined with oral antic
Eintrag öffnenDuloxetine Zentiva · 4.5 · Medicinal products metabolised by CYP2D6 Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was adm
Eintrag öffnenDuloxetine Zentiva · 4.8 · Discontinuation of duloxetine (particularly when abrupt) commonly leads to withdrawal symptoms. Dizziness, sen
Eintrag öffnenDuoTrav · 4.5 · The hypertensive reaction to sudden withdrawal of clonidine can be potentiated when taking beta blockers.
Eintrag öffnenDuoTrav · 4.5 · There is a potential for additive effects resulting in hypotension and/or marked bradycardia when ophthalmic b
Eintrag öffnenDynastat · 4.5 · 23 Lithium serum concentration should be monitored closely when initiating or changing parecoxib therapy in pa
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (38% and 24%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (38% and 24%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (62% and 19%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · Plasma exposure (AUC and Cmax) to valdecoxib was increased (62% and 19%, respectively) when coadministered wit
Eintrag öffnenDynastat · 4.5 · The effect of enzyme induction has not been studied. The metabolism of valdecoxib may increase when coadminist
Eintrag öffnen